Rasagiline in Participants Treated With Levodopa/Carbidopa Therapy

Study Title

Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.

Teva Identifier

TVP - 1012/135 Double Blind

ClinicalTrials.gov Identifier

NCT00203177

Study Status

Completed

Trial Condition(s)

Parkinson's Disease

Interventions

Drug: rasagiline mesylate | Drug: rasagiline mesylate 1.0 mg

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

30 Years and older

Trial Duration

10/01/2001 - 01/00/1900

Phase

Phase 3

Study Type

Interventional